Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Peladawnon Apr 24, 2024 11:24am
214 Views
Post# 36005149

The Calm Before the Storm.

The Calm Before the Storm.Volume has dropped way off, and that usually means that investors are watching and waiting for the next catalyst....
I decided to go back over the last years news releases, and the gaps between those releases....
.....there were approximately 28
.....out of the 28 gaps, there were only 7 that we waited 21 days or longer
......there were only 10 that we waited 14 days or longer
.....judging by these past year's numbers (and I know this is certainly no exact science, but I was bored and just killing time) the chances of not seeing a news release next week is only 30%, and only 25% of not seeing one next week
.....and, given the upcoming AGM in the first or second week of May, and the likelihood of management wanting to put something out in advance of that meeting, I think that decreases the chance of NOT seeing a release next week considerably, and if not, almost certainly the following Monday

.....if there is still a short position of more than 300,000, with this low volume,
we're going to see some desperate and hilarious scrambling to cover those shares in the next few days, possibly even beginning before today's close.....

......good luck to all decent honest investors, sucks to be you, shorty!
<< Previous
Bullboard Posts
Next >>